Gador SA Argentina is a pharmaceutical company with facilities in Darwin, Pilar, Catamarca and Cramer. It is dedicated to the development of pharmaceuticals for psychiatry, cardiology, diabetes, dentistry, gynecology, oncology, among others.
For Gador, the word “market” embodies not only a chart with figures, but it also represents every working day of the Medical Representatives in hospitals and clinics, ranging from large cities to small town, together with the Medical Board; the meetings, congresses and events, where the science tries hard to provide new solutions to the Community’s health.
The work of every Medical Representative is supported by Gador’s industrial, administrative and commercial structure, in order to achieve the expected results. Our motto is to be “devoted to people´s health”.
Quality, price, innovative molecules as well as the established validity of the active ingredients selected by the doctors due to their effectiveness and reliability, are key factors that enable Gador to place its products in the hands of 1.5 million patients every month.
Casa Matriz
Darwin 429
(C1414CUI) Buenos Aires, Argentina
Tel. (5411) 4858-9000
Gador’s first general director from outside of the family discusses his mission, Gador’s key to success, and his method for successfully leading a company in Argentina’s unpredictable and volatile market.…
“In the last decade, as a result of high and sustained growth, the Argentine pharmaceutical industry increased production by more than 240 percent, which speaks volumes about the capacity of…
The country president of AstraZeneca Argentina discusses the country’s patent laws, the work being done to bring innovation back to Argentina, and the challenge of a strong branded generics market…
When we met with Javier Lombar at IMS Argentina, he was explaining how a lot of multinational companies are using Argentina as a regional base of operations. Novartis is a…
Roemmers fue establecida en 1921. ¿Cómo paso de ser una empresa familiar a la empresa que es hoy, y cuáles han sido los desafíos en el cambio en la cultura…
The executive management of Nycomed said in an interview that ‘the tremendous growth of the pharmaceutical industry will not occur in either Europe or the United States, but in emerging…
Could you give us an overview of the generics sector in Argentina as it stands at the moment? The generics market in Argentina was started immediately after the regulation regarding…
Do you think this is a good moment for the Argentinean pharmaceutical industry to have international exposure? Indeed it is attractive, but we should keep the long term objectives on…
What have been the recent major milestones for Richmond? One of the milestones for Laboratorios Richmond was to have developed the first branded oncological generic in the world. For Laboratorios…
Biogen Idec’s arrival in Argentina has been very recent. Could you explain to our readers why the time was right to take back your licences and to set up in…
What was the vision behind the creation of the umbrella organisation Amega Biotech in 2005? What led you to consider setting up an organisation with this structure, and offering these…
UNC HEMODERIVADOS tiene una estructura muy especial y única con su asociación con la Universidad de Córdoba. ¿Cual fue la visión cuando se creó la empresa? El Laboratorio UNC Hemoderivados…
What has been the history of Massone in Argentina and how has it changed since you took over the company? Since the creation of the company by my grandfather I…
See our Cookie Privacy Policy Here
